Close

AcelRx Pharma (ACRX) Initiates Phase 3 IAP312 Study of Zalviso

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. INFY
5. SNV
6. TSLA
7. SPY
8. JWN
9. BX
10. BZUN


Go back to AcelRx Pharma (ACRX) Initiates Phase 3 IAP312 Study of Zalviso
ACELRX PHARMA (NASDAQ: ACRX) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $5.88 
Open $0.86    52 Week Low $2.40 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $-1.50 
Volume 500